Despite the growing influence of AI across industries, its adoption in pharmaceutical marketing remains limited. According to Statista, only 2% of pharma and healthcare companies have integrated AI into their sales and marketing strategies. Several factors contribute to this slow adoption, including regulatory challenges, resistance to change, a shortage of skilled professionals, and data integration issues. However, one key obstacle is often a limited understanding of AI’s capabilities in marketing. To bridge this gap, it is essential to explore the specific areas where AI can drive measurable impact and improve efficiency.
